Page last updated: 2024-10-25

ciprofloxacin and Granulocytic Leukemia, Chronic

ciprofloxacin has been researched along with Granulocytic Leukemia, Chronic in 4 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"Two patients with tendinitis by ciprofloxacin are described."4.79[Tendinitis due to fluoroquinolones. Description of 2 cases]. ( Collado, A; Hernández, MV; Muñoz-Gómez, J; Peris, P; Sierra, J, 1994)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Eslami, F1
Mahdavi, M1
Babaei, E1
Hussen, BM1
Mostafavi, H1
Shahbazi, A1
Hidayat, HJ1
Hernández, MV1
Peris, P1
Sierra, J1
Collado, A1
Muñoz-Gómez, J1
Carlens, S1
Ringdén, O1
Aschan, J1
Hägglund, H1
Ljungman, P1
Mattsson, J1
Remberger, M1
Hahn, T1
Shtalrid, M1
Berrebi, A1
Malach, L1
Barak, Y1
Rubinstein, E1

Reviews

1 review available for ciprofloxacin and Granulocytic Leukemia, Chronic

ArticleYear
[Tendinitis due to fluoroquinolones. Description of 2 cases].
    Medicina clinica, 1994, Sep-10, Volume: 103, Issue:7

    Topics: Adult; Bone Marrow Transplantation; Ciprofloxacin; Combined Modality Therapy; Female; Humans; Leukem

1994

Other Studies

3 other studies available for ciprofloxacin and Granulocytic Leukemia, Chronic

ArticleYear
Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family.
    Toxicology and applied pharmacology, 2020, 12-15, Volume: 409

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Do

2020
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Clinical transplantation, 1998, Volume: 12, Issue:2

    Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Cyclophosphamide; Disease-

1998
Interferon alpha-2a and ciprofloxacin synergistically inhibit leukemic cell growth.
    Journal of the National Cancer Institute, 1992, May-06, Volume: 84, Issue:9

    Topics: Bone Marrow Cells; Cell Division; Ciprofloxacin; Granulocyte-Macrophage Colony-Stimulating Factor; G

1992